Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab vs Ziv-Aflibercept in PDR Vitrectomy
NCT02590094Completed
- Sponsor
- Panhandle Eye Group
- Start
- Oct 2015
- Primary completion
- Jan 2019
- Modality
- Engineered Antibody Formats, Monoclonal Antibodies, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Randomised, open-label trial of bevacizumab and aflibercept in proliferative diabetic retinopathy (PDR), sponsored by Panhandle Eye Group. Started Oct 2015; status: completed.
02
Drugs
bevacizumabaflibercept
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT02590094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590094.